Titel

Merkliste
1 Ergebnisse

Image_3_Efficacy and safety of camrelizumab plus transarter..:

Ran You ; Qingyu Xu ; Qi Wang...
doi:10.3389/fonc.2022.816198.s003. , 2022

Link: https://doi.org/10.3389/fonc.2022.816198.s003

RT Journal
T1 <Title>Image_3_Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study.tif</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_20416845&Exemplar=1&LAN=DE
				
A1 Ran You
A1 Qingyu Xu
A1 Qi Wang
A1 Qingqiao Zhang
A1 Weizhong Zhou
A1 Chi Cao
A1 Xiangzhong Huang
A1 Honghai Ji
A1 Penghua Lv
A1 Hao Jiang
A1 You Lu
A1 Yong Jin
A1 Yongjun Li
A1 Long Cheng
A1 Weidong Wang
A1 Hao Xu
A1 Xiaoli Zhu
A1 Guowen Yin
YR 2022
K1 Cancer
K1 Cancer Cell Biology
K1 Cancer Diagnosis
K1 Cancer Genetics
K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
K1 Chemotherapy
K1 Haematological Tumours
K1 Molecular Targets
K1 Radiation Therapy
K1 Solid Tumours
K1 Oncology and Carcinogenesis not elsewhere classified
K1 camrelizumab
K1 transarterial chemoembolization
K1 hepatocellular carcinoma
K1 survival
K1 adverse event
JF doi:10.3389/fonc.2022.816198.s003
LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.816198.s003
DO https://doi.org/10.3389/fonc.2022.816198.s003
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)